Skip to content

18793 - Human Photoallergy Test

Human Photoallergy Test

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02750488
Enrollment
54
Registered
2016-04-25
Start date
2016-05-09
Completion date
2016-07-01
Last updated
2018-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sunscreening Agents

Brief summary

To evaluate the potential of a test material to produce a photoallergic response.

Interventions

50 μl/ cm2 of the test article is applied directly to two sites on the skin and covered with the appropriate patch. Twenty-four (24) hours later, the patches are removed. The test sites are lightly wiped with a dry cloth/tissue and 3μl/ cm2 of test article is reapplied directly to the skin of the test site designated for irradiation, and lightly spread over the test site. Forty-eight (48) hours later the procedure is repeated to the same test sites. This process is repeated twice weekly for a total of six exposures.

One site is patched without treatment as control

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* be male or female between the ages of 18 and 60 inclusive * be lightly pigmented (Fitzpatrick Skin Type I, II, III) * have read and signed the written Informed Consent Form and have completed a HIPAA Authorization Form (Health Insurance Portability and Accountability Act) in conformance with 45CFR Parts 160 and 164 * be in general good health as determined by the subject's medical history and in the discretion of the investigator

Exclusion criteria

* have a visible sunburn * have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses * have a known hypersensitivity or allergy against any of the active and non-active ingredients of the investigational products * subjects who are employees of the CRO (Contract Research Organization) and/or Bayer or is a household member of an employee

Design outcomes

Primary

MeasureTime frame
Intensity of skin reactions is evaluated by 5 point scaleUp to 72 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026